Showing 101 - 120 results of 15,455 for search '(((( a largest decreases ) OR ( ((b large) OR (a large)) decrease ))) OR ( i large decrease ))', query time: 1.86s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108

    Temporal trends in large carnivore attacks on humans in different regions of the world. by Giulia Bombieri (8613945)

    Published 2023
    “…<p>(<b>A</b>) The number of attacks shows a nonlinear increase over the years, as evidenced by fitting the general additive mixed model of the number of attacks-1 as a function of the smoothing factor “year.” …”
  9. 109

    Table1_A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China.docx by Chunli Yang (2087218)

    Published 2022
    “…Additionally, in the 70–80-year group, reduction in chemotherapy dose was associated with a significantly shorter OS, with a 2-year OS rate of 74.4% in the full dose group, compared to 67.1% for the decreased-dose group (p = 0.044).…”
  10. 110
  11. 111

    DataSheet1_Adverse childhood experiences, brain function, and psychiatric diagnoses in a large adult clinical cohort.pdf by David B. Keator (19842939)

    Published 2024
    “…However, no study has explored these associations in a large clinical population to identify brain regions that may mediate the relationship between ACEs and psychiatric diagnoses. …”
  12. 112

    Image_1_Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis.jpeg by Shengling Ma (9119243)

    Published 2020
    “…A decreasing trend was observed in the ES cohort after 2002, while the rate of RT utilization remained stable in the AS cohort over the past three decades. …”
  13. 113

    Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx by Dewan Zhao (21547445)

    Published 2025
    “…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119
  20. 120